Complement activation in patients with neuromyelitis optica.
The role of complement has been demonstrated in experimental models of neuromyelitis optica (NMO), however, only few studies have analysed complement components longitudinally in NMO patients. We measured serum or plasma concentrations of anti-C1q antibodies and complement split products C3a and C4a...
Những tác giả chính: | Nytrova, P, Potlukova, E, Kemlink, D, Woodhall, M, Horakova, D, Waters, P, Havrdova, E, Zivorova, D, Vincent, A, Trendelenburg, M |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2014
|
Những quyển sách tương tự
-
Complement activation in patients with neuromyelitis optica
Bằng: Nytrova, P, et al.
Được phát hành: (2014) -
C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica
Bằng: Nytrova, P, et al.
Được phát hành: (2013) -
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Bằng: Saadoun, S, et al.
Được phát hành: (2010) -
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Bằng: Waters, P, et al.
Được phát hành: (2016) -
IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
Bằng: Jacob, S, et al.
Được phát hành: (2008)